Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fakhouri, F.
Right arrow Articles by Chatziantoniou, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fakhouri, F.
Right arrow Articles by Chatziantoniou, C.
J Am Soc Nephrol 12:2701-2710, 2001
© 2001 American Society of Nephrology

Angiotensin II Activates Collagen Type I Gene in the Renal Cortex and Aorta of Transgenic Mice through Interaction with Endothelin and TGF-ß

Fadi Fakhouri*, Sandrine Placier*, Raymond Ardaillou*, Jean-Claude Dussaule{dagger} and Christos Chatziantoniou*

*INSERM U.489, Hôpital Tenon, Paris, France; and {dagger}AP-HP, Laboratoire de Physiologie, Faculté de Médecine St Antoine, Paris, France.

Correspondence to Dr. Christos Chatziantoniou, INSERM U.489, Hôpital Tenon, Paris 75020, France. Phone: 331-56-01-66-58; Fax: 331-43-64-54-48; E-mail: christos.chatziantoniou{at}tnn.ap-hop-paris.fr

ABSTRACT. Hypertension is frequently associated with the development of renal vascular fibrosis. This pathophysiologic process is due to the abnormal formation of extracellular matrix proteins, mainly collagen type I. In previous studies, it has been observed that the pharmacologic blockade of angiotensin II (Ang II) or endothelin (ET) blunted the development of glomerulo- and nephroangiosclerosis in nitric oxide-deficient hypertensive animals by inhibiting collagen I gene activation. The purpose of this study was to investigate whether and how AngII interacts with ET to activate the collagen I gene and whether transforming growth factor-ß (TGF-ß) could be a player in this interaction. Experiments were performed in vivo on transgenic mice harboring the luciferase gene under the control of the collagen I-{alpha}2 chain promoter (procol{alpha}2[I]). Bolus intravenous administration of AngII or ET produced a rapid, dose-dependent activation of collagen I gene in aorta and renal cortical slices (threefold increase over control at 2 h, P < 0.01). The AngII-induced effect on procol{alpha}2(I) was completely inhibited by candesartan (AngII type 1 receptor antagonist) and substantially blunted by bosentan (dual ET receptor antagonist) (P < 0.01), whereas the ET-induced activation of collagen I gene was blocked only by bosentan. In subsequent experiments, TGF-ß (also administered intravenously) produced a rapid increase of procol{alpha}2(I) in aorta and renal cortical slices (twofold increase over control at 1 h, P < 0.01) that was completely blocked by decorin (scavenger of the active form of TGF-ß). In addition, decorin attenuated the activation of collagen I gene produced by AngII (P < 0.01). These data indicate that AngII can activate collagen I gene in aorta and renal cortex in vivo by a mechanism(s) requiring participation and/or cooperation of ET and TGF-ß.




This article has been cited by other articles:


Home page
Eur Heart JHome page
W. H. Wilson Tang, W. Tong, K. Shrestha, Z. Wang, B. S. Levison, B. Delfraino, B. Hu, R. W. Troughton, A. L. Klein, and S. L. Hazen
Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure
Eur. Heart J., October 2, 2008; 29(20): 2506 - 2513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Shweke, N. Boulos, C. Jouanneau, S. Vandermeersch, G. Melino, J.-C. Dussaule, C. Chatziantoniou, P. Ronco, and J.-J. Boffa
Tissue Transglutaminase Contributes to Interstitial Renal Fibrosis by Favoring Accumulation of Fibrillar Collagen through TGF-{beta} Activation and Cell Infiltration
Am. J. Pathol., September 1, 2008; 173(3): 631 - 642.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Xia, E. Seckin, Y. Xiang, M. Vranesic, W. B. Mathews, K. Hong, D. A. Bluemke, L. O. Lerman, and Z. Szabo
Positron-Emission Tomography Imaging of the Angiotensin II Subtype 1 Receptor in Swine Renal Artery Stenosis
Hypertension, February 1, 2008; 51(2): 466 - 473.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Castanares, M. Redondo-Horcajo, N. Magan-Marchal, P. ten Dijke, S. Lamas, and F. Rodriguez-Pascual
Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation
J. Cell Sci., April 1, 2007; 120(7): 1256 - 1266.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. A. Miller, D. Z. Cherney, J. A. Duncan, V. Lai, K. D. Burns, C. R.J. Kennedy, J. Zimpelmann, W. Gao, D. C. Cattran, and J. W. Scholey
Gender Differences in the Renal Response to Renin-Angiotensin System Blockade
J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2554 - 2560.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Rutschow, J. Li, H.-P. Schultheiss, and M. Pauschinger
Myocardial proteases and matrix remodeling in inflammatory heart disease
Cardiovasc Res, February 15, 2006; 69(3): 646 - 656.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Page, H. Reich, J. Zhou, V. Lai, D. C. Cattran, J. W. Scholey, and J. A. Miller
Endothelial Nitric Oxide Synthase Gene/Gender Interactions and the Renal Hemodynamic Response to Angiotensin II
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3053 - 3060.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Rodriguez-Vita, M. Ruiz-Ortega, M. Ruperez, V. Esteban, E. Sanchez-Lopez, J. J. Plaza, and J. Egido
Endothelin-1, via ETA Receptor and Independently of Transforming Growth Factor-{beta}, Increases the Connective Tissue Growth Factor in Vascular Smooth Muscle Cells
Circ. Res., July 22, 2005; 97(2): 125 - 134.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. M. Pollock
Endothelin, Angiotensin, and Oxidative Stress in Hypertension
Hypertension, April 1, 2005; 45(4): 477 - 480.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. Mishra, P. Leahy, and M. S. Simonson
Gene expression profile of endothelin-1-induced growth in glomerular mesangial cells
Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1109 - C1115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Finckenberg, K. Inkinen, J. Ahonen, S. Merasto, M. Louhelainen, H. Vapaatalo, D. Muller, D. Ganten, F. Luft, and E. Mervaala
Angiotensin II Induces Connective Tissue Growth Factor Gene Expression via Calcineurin-Dependent Pathways
Am. J. Pathol., July 1, 2003; 163(1): 355 - 366.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Garg and K. N. Pandey
Angiotensin II-Mediated Negative Regulation of Npr1 Promoter Activity and Gene Transcription
Hypertension, March 1, 2003; 41(3): 730 - 736.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP